Botulinum Antitoxin Heptavalent (2026)

SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE ACTING AS PART OF THE CROWN THROUGH UK HEALTH SECURITY AGENCY

This public procurement record has 2 releases in its history.

Tender

15 Jul 2026 at 10:45

Planning

26 Jun 2026 at 11:27

Summary of the contracting process

The procurement process for the "Botulinum Antitoxin Heptavalent (2026)" is being carried out by the Secretary of State for Health and Social Care, acting through the UK Health Security Agency (UKHSA). This tender falls under the pharmaceutical products category and seeks suppliers for the provision of Botulinum Antitoxin Heptavalent. UKHSA is located in London, UK, and the procurement process is currently in the tender stage. Key dates include a tender submission deadline on 13th August 2026 and an enquiry period ending on 30th July 2026. The competitive flexible procedure, involving a single submission stage and an optional negotiation stage, aims to optimise risk management and value. The contract is valued at £1.00 GBP, with provisions for a contract period starting on 5th October 2026 until 4th October 2028, with potential renewal options.

This tender presents significant opportunities for businesses operating within the pharmaceutical industry. The procurement process is designed for competitive flexibility, allowing businesses to present comprehensive proposals addressing technical, commercial, and quality aspects. Companies with expertise in delivering pharmaceutical products, managing production schedules, and maintaining precise shelf-life guarantees stand a good chance to compete effectively. The project is also suitable for small and medium-sized enterprises, offering them the opportunity to establish or expand their presence within governmental health supply chains. With the emphasis on technical risk management and social value, businesses that align their operations with these criteria will find this tender conducive to growth and innovation in their offerings.

How relevant is this notice?

Notice Title

Botulinum Antitoxin Heptavalent (2026)

Notice Description

The provision of Botulinum Antitoxin Heptavalent

Planning Information

Suppliers are invited to submit responses including the following: Product Information: - Product name and description - Available dose/pack sizes and formats - Any minimum order quantities Lead Times and Supply: - Standard lead times based on contract starting September 2026 If your organisation is interested in this requirement, please provide the above information to commercial.preparednessandcountermeasures@ukhsa.gov.uk by COP 10th July 2026. Once the tender is published, bidders will be required to sign a Non-Disclosure Agreement (NDA) prior to gaining access to the tender documentation.

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-06be1b
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/066675-2026
Current Stage
Tender
All Stages
Planning, Tender

Procurement Classification

Notice Type
UK4 - Tender Notice
Procurement Type
Standard
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Competitive flexible procedure
Tender Suitability
SME
Awardee Scale
Not specified

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products


CPV Codes

33600000 - Pharmaceutical products

Notice Value(s)

Tender Value
£1
Lots Value
£1
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
15 Jul 2026Today
Submission Deadline
13 Aug 20264 weeks to go
Future Notice Date
17 Jul 20261 day to go
Award Date
Not specified
Contract Period
4 Oct 2026 - 4 Oct 2028 2-3 years
Recurrence
Not specified

Notice Status

Tender Status
Active
Lots Status
Active
Awards Status
Not Specified
Contracts Status
Not Specified

Contracting Authority (Buyer)

Main Buyer
SECRETARY OF STATE FOR HEALTH AND SOCIAL CARE ACTING AS PART OF THE CROWN THROUGH UK HEALTH SECURITY AGENCY
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
LONDON
Postcode
E14 4PU
Post Town
East London
Country
England

Major Region (ITL 1)
TLI London
Basic Region (ITL 2)
TLI4 Inner London - East
Small Region (ITL 3)
TLI42 Tower Hamlets
Delivery Location
Not specified

Local Authority
Tower Hamlets
Electoral Ward
Canary Wharf
Westminster Constituency
Poplar and Limehouse

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

{
    "tag": [
        "compiled"
    ],
    "id": "ocds-h6vhtk-06be1b-2026-07-15T11:45:38+01:00",
    "date": "2026-07-15T11:45:38+01:00",
    "ocid": "ocds-h6vhtk-06be1b",
    "initiationType": "tender",
    "parties": [
        {
            "id": "GB-PPON-PBMQ-7576-DVGW",
            "name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency",
            "identifier": {
                "scheme": "GB-PPON",
                "id": "PBMQ-7576-DVGW"
            },
            "address": {
                "streetAddress": "10 South Colonnade",
                "locality": "London",
                "postalCode": "E14 4PU",
                "country": "GB",
                "countryName": "United Kingdom",
                "region": "UKI42"
            },
            "contactPoint": {
                "email": "commercial.preparednessandcountermeasures@ukhsa.gov.uk"
            },
            "roles": [
                "buyer"
            ],
            "details": {
                "url": "https://www.gov.uk/government/organisations/uk-health-security-agency",
                "classifications": [
                    {
                        "id": "publicAuthorityCentralGovernment",
                        "scheme": "UK_CA_TYPE",
                        "description": "Public authority - central government"
                    }
                ]
            }
        }
    ],
    "buyer": {
        "id": "GB-PPON-PBMQ-7576-DVGW",
        "name": "Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency"
    },
    "planning": {
        "milestones": [
            {
                "id": "engagement",
                "type": "engagement",
                "description": "Suppliers are invited to submit responses including the following: Product Information: - Product name and description - Available dose/pack sizes and formats - Any minimum order quantities Lead Times and Supply: - Standard lead times based on contract starting September 2026 If your organisation is interested in this requirement, please provide the above information to commercial.preparednessandcountermeasures@ukhsa.gov.uk by COP 10th July 2026. Once the tender is published, bidders will be required to sign a Non-Disclosure Agreement (NDA) prior to gaining access to the tender documentation.",
                "dueDate": "2026-07-10T23:59:59+01:00",
                "status": "scheduled"
            }
        ],
        "documents": [
            {
                "id": "060298-2026",
                "documentType": "marketEngagementNotice",
                "noticeType": "UK2",
                "description": "Preliminary market engagement notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/060298-2026",
                "datePublished": "2026-06-26T12:27:08+01:00",
                "format": "text/html"
            }
        ]
    },
    "tender": {
        "id": "C455790",
        "legalBasis": {
            "id": "2023/54",
            "scheme": "UKPGA",
            "uri": "https://www.legislation.gov.uk/ukpga/2023/54/contents"
        },
        "title": "Botulinum Antitoxin Heptavalent (2026)",
        "description": "The provision of Botulinum Antitoxin Heptavalent",
        "items": [
            {
                "id": "1",
                "additionalClassifications": [
                    {
                        "scheme": "CPV",
                        "id": "33600000",
                        "description": "Pharmaceutical products"
                    }
                ],
                "deliveryAddresses": [
                    {
                        "region": "UK",
                        "country": "GB",
                        "countryName": "United Kingdom"
                    },
                    {
                        "region": "UK",
                        "country": "GB",
                        "countryName": "United Kingdom"
                    }
                ],
                "relatedLot": "1"
            }
        ],
        "value": {
            "amountGross": 1,
            "amount": 1,
            "currency": "GBP"
        },
        "mainProcurementCategory": "goods",
        "aboveThreshold": true,
        "lots": [
            {
                "id": "1",
                "suitability": {
                    "sme": true
                },
                "contractPeriod": {
                    "startDate": "2026-10-05T00:00:00+01:00",
                    "endDate": "2028-10-04T23:59:59+01:00",
                    "maxExtentDate": "2030-10-04T23:59:59+01:00"
                },
                "status": "active",
                "value": {
                    "amountGross": 1,
                    "amount": 1,
                    "currency": "GBP"
                },
                "awardCriteria": {
                    "criteria": [
                        {
                            "type": "quality",
                            "name": "Social Value",
                            "numbers": [
                                {
                                    "number": 10,
                                    "weight": "percentageExact"
                                }
                            ]
                        },
                        {
                            "type": "price",
                            "name": "Commercial",
                            "numbers": [
                                {
                                    "number": 80,
                                    "weight": "percentageExact"
                                }
                            ]
                        },
                        {
                            "type": "quality",
                            "name": "Technical - Risk",
                            "numbers": [
                                {
                                    "number": 10,
                                    "weight": "percentageExact"
                                }
                            ]
                        }
                    ]
                },
                "hasRenewal": true,
                "renewal": {
                    "description": "1+1"
                }
            }
        ],
        "communication": {
            "futureNoticeDate": "2026-07-17T23:59:59+01:00"
        },
        "status": "active",
        "procurementMethod": "open",
        "procurementMethodDetails": "Competitive flexible procedure",
        "procedure": {
            "features": "1. Single Submission Stage - Full Tender Evaluation Suppliers will be invited to submit full and final tenders at the initial stage. Submissions must comprehensively address: * Technical Requirements: Including delivery schedules, product quality, risk management, and social value commitments. * Commercial Requirements: Including pricing, shelf-life guarantees, business continuity provisions, and contractual flexibility. 2. Optional Negotiation Stage - Risk Mitigation & Value Optimisation Following evaluation, the Authority reserves the right to: * Directly award to the highest scoring tender if it meets all critical success criteria. * Or, initiate a single negotiation round with one or both suppliers to refine specific elements of their proposals, where clarification or enhancement is required to meet operational or strategic needs."
        },
        "submissionMethodDetails": "UKHSA are carrying out a competitive flexible competition for the provision of Botulinum Antitoxin Heptavalent. As part of this requirement, UKHSA requires all tenderers to sign a Non-Disclosure Agreement before being given access to the tender documents. A copy of our Non-Disclosure Agreement is available in the Documents section. Please complete and electronically sign and return to UKHSA through the Atamis messaging system. The full ITT and specification will be released to tenderers who have a fully signed NDA, through a separate Atamis project. The tender submission deadline is Thursday 13th August. Tenderers are therefore encouraged to complete and return the NDA as early as possible to allow sufficient time to access the tender documents and prepare and submit a compliant bid. If there are any questions, please ask through the Atamis messaging system. https://health-family.force.com/s/Welcome",
        "submissionTerms": {
            "electronicSubmissionPolicy": "allowed",
            "languages": [
                "en"
            ]
        },
        "tenderPeriod": {
            "endDate": "2026-08-13T17:00:00+01:00"
        },
        "enquiryPeriod": {
            "endDate": "2026-07-30T12:00:00+01:00"
        },
        "awardPeriod": {
            "endDate": "2026-09-30T23:59:59+01:00"
        },
        "documents": [
            {
                "id": "conflictOfInterest",
                "documentType": "conflictOfInterest"
            },
            {
                "id": "066675-2026",
                "documentType": "tenderNotice",
                "noticeType": "UK4",
                "description": "Tender notice on Find a Tender",
                "url": "https://www.find-tender.service.gov.uk/Notice/066675-2026",
                "datePublished": "2026-07-15T11:45:38+01:00",
                "format": "text/html"
            }
        ],
        "riskDetails": "Compliant licensing required."
    },
    "language": "en"
}